Clinical Trial Update: Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of lansoprazole in patients with frequent nighttime heartburn. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• PREVACID (LANSOPRAZOLE)

Snippet

Sponsor: Novartis | Conditions: Frequent Heartburn | Phase 3 | Status: COMPLETED